TECH OUTLOOK 6JULY - 2021TECH OUTLOOKEditorialStacey Smith Editor-in-Chiefeditor@pharmatechoutlook.comIn the epoch of digitalization, technology has become the lifeblood of most pharmaceutical organizations across verticals and the immunotherapy realm is not an exception. From automating treatment procedures to devising out-of-the-box solutions based on latest technologies, immunotherapy experts are leaving no stone unturned in modernizing their existing legacy models. In this regard, several immunotherapy solutions today are targeted to provide personalized care to patients. Technologies like machine learning and predictive analytics are playing a pivotal role in highlighting patient-specific reasons of diseases and subsequently generate a database of their health symptoms for medical reference. In addition, the widely popular connected devices and big data algorithms are paving the way for new routes in immunotherapy procedures. Standing at the cusp of immunotherapy technologies, there are a wide range of solution providers which offer the latest methods best suited for the next generation of pharma needs. To help leaders navigate through the list of immunotherapy solution providers, our panel comprising of CEOs, CIOs, VCs, industry analysts, and the editorial board of Pharma Tech Outlook has narrowed down the top companies in this landscape that exhibit competence in delivering robust immunotherapy innovations. Equipped with innovative technological capabilities, these enlisted firms are transforming the pharma realm at the cloverleaf of various disruptive technologies. We hope this issue of Pharma Tech Outlook helps you build the partnership you and your organization need to foster an environment driven by robust and efficient technology. Let us know your thoughts! Copyright © 2021 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.JULY - 16 - 2021, Vol 07 - Issue 05 (ISSN 2644-2787) Published by ValleyMedia, Inc. To subscribe to Pharma Tech OutlookVisit www.pharmatechoutlook.com *Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffEditor-in-ChiefStacey SmithVisualizerRonald DonovanAsher BlakeEditorial StaffAaron Pierce Ava GarciaJenna VegasCarolynn Walters Justin SmithPaul BarberSalesBrian Thomasbrian@pharmatechoutlook.comPhone: 510.556.2402sales@pharmatechoutlook.comeditor@pharmatechoutlook.commarketing@pharmatechoutlook.comEmail:Contact Us:Phone:510.556.2402, Fax:510-894-8405TECH OUTLOOK
< Page 5 | Page 7 >